Improving drug development for diverse populations
Official title: 2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
Funded at University of California Riverside · NIH-10933464 · Data updated 2026-11-12
This study is working to make sure that new medications are safe and effective for everyone, especially for African Americans and Latinos, by training a diverse group of researchers and improving how drugs are developed.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,290,685 |
| NIH project number | 5U54CA285114-02 |
| Project ID | NIH-10933464 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include African American and Latino individuals who may be affected by the disparities in drug efficacy and safety.
✕Less likely to help
Patients who are not part of the African American or Latino populations may not receive direct benefits from this research.
What this research studies
This research focuses on addressing disparities in drug development by ensuring that medications are tested and optimized for diverse populations, particularly African Americans and Latinos. The project aims to build resources, infrastructure, and training programs that will mentor a new generation of researchers who reflect the diversity of the communities they serve. By enhancing collaboration between institutions, the research seeks to reduce the inequities present in the drug discovery pipeline, ensuring that new drugs are safe and effective for all populations.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medications for diverse populations, reducing health disparities.
How similar studies have gone: Other research has shown success in addressing health disparities through community engagement and targeted drug development, making this approach promising.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Martinez, Ernest — University of California Riverside
- Study coordinator: Martinez, Ernest
Related research
Other NIH-funded projects on the same topics.
-
Cellular programming by plant signaling in cancer and other diseases
Scientists are studying how plant cell signals control gene activity in the nucleus and mitochondria to understand faulty regulation that can occur in cancers and other disorders.
-
Caveolin-1 helps brain vessels stay healthy after juvenile concussion
A study in kids and young adults looks at how a protein called Caveolin-1 affects brain blood vessels after a mild concussion and whether targeting it could protect long-term brain health.
-
How tiny cell antennae control signals linked to birth defects and cancer
Researchers are looking for new proteins in cells' tiny antennae that control signals involved in certain birth defects and cancers to point toward future treatments.
-
New ways to make natural compounds that could fight cancer, Alzheimer's, and inflammation
A scientist team will make and test natural-looking molecules to see if they can block proteins linked to cancer, Alzheimer's disease, and inflammatory conditions.
-
Promoting Coping Skills to Reduce Health Gaps in Teens and Young Adults
A study tests a shift-and-persist coping approach to help racial/ethnic minority teens and young adults handle stress and reduce risks for chronic disease.
-
Laser particle barcoding to track live cells and their omics in breast cancer
A new technique uses special laser-coded particles to follow individual breast cancer cells in real time while linking their live behavior to multi-omics data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.